Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Bioorg Med Chem ; 24(4): 802-11, 2016 Feb 15.
Article in English | MEDLINE | ID: mdl-26780833

ABSTRACT

A set of novel selenohydantoins were synthesized via a convenient and versatile approach involving the reaction of isoselenocyanates with various amines. We also revealed an unexpected Z→E isomerization of pyridin-2-yl-substituted selenohydantoins in the presence of Cu(2+) cations. The detailed mechanism of this transformation was suggested on the basis of quantum-chemical calculations, and the key role of Cu(2+) was elucidated. The obtained compounds were subsequently evaluated against a panel of different cancer cell lines. As a result, several molecules were identified as promising micromolar hits with good selectivity index. Instead of analogous thiohydantoins, which have been synthesized previously, selenohydantoins demonstrated a relatively high antioxidant activity comparable (or greater) to the reference molecule, Ebselen, a clinically approved drug candidate. The most active compounds have been selected for further biological trials.


Subject(s)
Antineoplastic Agents/chemical synthesis , Antioxidants/chemical synthesis , Hydantoins/chemical synthesis , Organoselenium Compounds/chemical synthesis , Antineoplastic Agents/pharmacology , Antioxidants/pharmacology , Azoles/pharmacology , Cell Line, Tumor , Cell Survival/drug effects , Copper/chemistry , Cyanates/chemistry , Drug Screening Assays, Antitumor , Glutathione Peroxidase/antagonists & inhibitors , Glutathione Peroxidase/chemistry , Humans , Hydantoins/pharmacology , Inhibitory Concentration 50 , Isoindoles , Organoselenium Compounds/pharmacology , Pyridines/chemistry , Quantum Theory , Stereoisomerism , Structure-Activity Relationship
2.
Chemistry ; 22(4): 1223-7, 2016 Jan 22.
Article in English | MEDLINE | ID: mdl-26251074

ABSTRACT

A rapid new approach to produce biologically relevant bisindoles, namely indolyltetrahydrocarbazoles and indolo[3,2-b]carbazoles, has been developed, based on the Ga(OTf)3 -catalyzed [3+3] cyclodimerization of indole-derived donor-acceptor cyclopropanes. Chemoselectivity of the process depends on the location of the three-membered ring at the indole core.

3.
Org Lett ; 17(4): 770-3, 2015 Feb 20.
Article in English | MEDLINE | ID: mdl-25668029

ABSTRACT

(3 + 2)-Annulation of donor-acceptor cyclopropanes to alkynes induced by both Lewis and Brønsted acids has been developed. The reaction provides a rapid approach to functionalized indenes displaying intense visible emission (λmax = 430 nm, Φ = 0.28-0.34).


Subject(s)
Alkynes/chemistry , Cyclopropanes/chemistry , Lewis Acids/chemistry , Catalysis , Indenes/chemistry , Molecular Structure , Stereoisomerism
4.
Chem Commun (Camb) ; 49(98): 11482-4, 2013 Dec 21.
Article in English | MEDLINE | ID: mdl-23900594

ABSTRACT

A novel Lewis acid-catalyzed domino (3+2)-cyclodimerization of 2-arylcyclopropane-1,1-diesters and related stepwise cross-reaction of two different cyclopropanes were developed. These processes provide efficient and highly stereoselective access to polyoxygenated indanes and cyclopentannulated heteroarene derivatives, which display significant cytotoxicity against several lines of cancer cells (IC50 of 10(-6)-10(-5) M) while being non-toxic for normal cells.


Subject(s)
Hydrocarbons/chemistry , Cell Line, Tumor , Cell Survival/drug effects , Dimerization , Humans , Hydrocarbons/pharmacology , Lewis Acids/chemistry , Stereoisomerism
5.
Chemistry ; 19(21): 6586-90, 2013 May 17.
Article in English | MEDLINE | ID: mdl-23576404

ABSTRACT

Quo vadis? The Lewis acid catalyzed reaction of (hetero)aryl-derived donor-acceptor cyclopropanes with alkenes can be selectively directed along a [3+2] annulation pathway (see scheme). This new process provides convenient and efficient access to indanes and other cyclopentannulated (hetero)arenes, among which polyoxygenated 1-arylindanes exhibit significant cytotoxicity against several cancer cell lines with an IC50 of 10(-6)-10(-5) M.


Subject(s)
Cyclopropanes/chemistry , Lewis Acids/chemistry , Alkenes/chemistry , Carbon , Catalysis , Cycloaddition Reaction , Cyclopropanes/chemical synthesis , Cyclopropanes/pharmacology , Humans , Molecular Structure , Stereoisomerism
SELECTION OF CITATIONS
SEARCH DETAIL
...